| CENTER ID: | TogoA.00877.b |
| ORGANISM: | Toxoplasma gondii ME49 |
| ASSOCIATED DISEASE: | Toxoplasmosis |
| CURRENT STATUS: | purified |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
IIIB |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| TogoA.00877.b.A2.GE30691 | from TgCentrin2 construct | 74 | 241 |
| METHOD | RESULTS |
|---|---|
| comparative modelling | Robetta_88701 |
| RESOURCE | REFERENCE ID |
|---|---|
| EuPathDB: | ToxoDB:TGME49_250340 |
| RefSeq: | XP_002367347.1 |
| UniProt: | B6KHM3 |
| HARVESTED ON: | data unavailable |
| SEQUENCED ON: | 9/28/2010 |
| EXPECTED MW: | 21kDa |
| OBSERVED MW: | 17kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
| TOTAL EXPRESSION LEVEL: | High Expression |
| SOLUBLE EXPRESSION LEVEL | High Expression |
| EXPRESSION HOST: | data unavailable |
| SEQUENCING RESULT: | pass |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 100 |